Enrollment and Retention

Slides:



Advertisements
Similar presentations
The ENCORE Study Cardiovascular Benefits Associated With the DASH Diet Alone and in Combination with Exercise and Weight Reduction in Men and Women with.
Advertisements

Slides current until 2008 Nutritional needs of people with type 1 diabetes and type 2 diabetes.
Nonsense Mutations in PCSK9 and Cardiovascular Risk Factors among 3363 Black Participants in the Study Jonathan C.Cohen, et al, N Engl J Med 2006;354:
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
Clinical Approaches to address the Obesity epidemic Ken Fujioka, M.D. Director of Nutrition and Metabolic Research Director of The Center for Weight Management.
Journal Club Alcohol and Health: Current Evidence January–February 2007.
Sherry L. Pagoto, Carol Curtin, Linda Bandini, Sarah Anderson, Kristin Schneider, Jamie Bodenlos, and Yunsheng Ma Division of Preventive and Behavioral.
Minimally Invasive Surgery Symposium Modest Weight Loss in T2 DM: Lessons from the Look AHEAD Trial Donna H. Ryan, MD Pennington Biomedical Research Center.
Medical Therapy of Prostate Symptoms (MTOPS) Jeannette Y. Lee, Ph.D. University of Alabama at Birmingham.
Linda Snetselaar, PhD, RD Professor Interim Chair of the Department of Community and Behavioral Health College of Public Health University of Iowa.
Frank B. Hu et al N Engl J Med 2004; 351: Body-Mass Index and Relative Risk of Death from All Causes during 24 Years of Follow-up.
Medical Management of obesity Perinatal ANGELS Conference Feb 17, 2005 Philip A. Kern.
Journal Club 亀田メディカルセンター 糖尿病内分泌内科 Diabetes and Endocrine Department, Kameda Medical Center 松田 昌文 Matsuda, Masafumi 2008 年9月 25 日 8:20-8:50 B 棟8階 カンファレンス室.
The TRial Of Preventing HYpertension (TROPHY) TROPHY.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015 Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical Associate Professor.
K Keep active and maintain a healthy body weight. Keep active and maintain a healthy body weight. A healthy body weight can reduce the risk for high blood.
Lars Sjöström et al N Engl J Med 2004; 351: Characteristics of the Subjects at the Time of Matching and at the Time of the Inclusion Examination.
Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:
A Diabetes Outcome Progression Trial
 GLP-1 agonists have shown to help patients lose weight  Mechanism of GLP-1 agonists  Cardioprotective effects of GLP-1 agonists  GLP-1 agonists and.
The ACTIVE Investigators. N Engl J Med 2009 Apr 3 [Epub]
Background There are 12 different types of medications to lower blood sugar levels in patients with type 2 diabetes. It is widely agreed upon that metformin.
Int J Clin Pract, December 2013, 67, 12,
HIGH BLOOD PRESSURE (HYPERTENSION) RAKAN ASSAF M. AL-ASSAF
Baseline Prevalence of Metabolic Syndrome and Individual Components Among 4258 Older Adults Dariush Mozaffarian, et al. Arch Intern Med. 2008;168:
CDA exercise guidelines 150 minutes moderate – intensity (60 – 70% of max) aerobic over minimum 3 non consecutive days PLUS resistance exercise 3.
Date of download: 6/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Sodium Reduction and Weight Loss in the Treatment.
호흡기내과 금요저널컨퍼런스 R3 박재훈 / Prof. 임효석.  Obesity & obstructive sleep apnea(OSA) ◦ linked to insulin resistance, dyslipidemia, HTN, inflammation ◦
Date of download: 6/22/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Exercise and Weight Loss Reduce Blood Pressure in.
The Role of Behavior Modification in Obesity Therapy.
Date of download: 6/24/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Aripiprazole, an Antipsychotic With a Novel Mechanism.
Date of download: 6/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of the DASH Diet Alone and in Combination.
Early Neuromuscular Electrical Stimulation to Improve Quadriceps Muscle Strength After Total Knee Arthroplasty: A Randomized Controlled Trial by Jennifer.
1 Body-Mass Index and Mortality in Korean Men and Women Sun Ha Jee, Ph.D., Jae Woong Sull, Ph.D., Jung yong Park, Ph.D., Sang-Yi Lee, M.D. From the Department.
Date of download: 7/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Benefits of Lifestyle Modification in the Pharmacologic.
Multicenter, Placebo-Controlled Trial
Effect of fish oil supplementation on serum triglycerides, LDL cholesterol and LDL subfractions in hypertriglyceridemic adults  B. Oelrich, A. Dewell,
The SPRINT Research Group
Copyright © 2010 American Medical Association. All rights reserved.
Fig. 2. Changes in blood pressure, body weight, and echocardiographic findings. (A) Mean blood pressure was significantly decreased in the fimasartan-treated.
CORAL Trial design: Patients with renal artery stenosis and hypertension or chronic kidney disease were randomized to renal artery stenting (n = 467) vs.
Neal B, et al. Diabetes Care 2015;38:403–411
Placebo group 5-mg rimonabant group p 20-mg rimonabant group
Community-Based Argentine Tango Dance Program Is Associated With Increased Activity Participation Among Individuals With Parkinson's Disease  Erin R.
Ledipasvir-Sofosbuvir +/- Ribavirin in HCV Genotype 1 ION-2
Exercise and adult women’s health
Three Steps to Interpret Clinical Trials
Chapter 28 Nutrition, Lifestyle, and Hypertension
Lifestyle Modification for the Management of Obesity
FOURIER Trial design: Patients with established cardiovascular disease on statin therapy were randomized to evolocumab 140 mg subcutaneous every 2 weeks.
Enrollment and Outcomes
Baseline Characteristics of the Subjects
Trial profile Luc F Van Gaal, Lancet 2005;365:1389.
Flow of Patients Through Trial
Baseline Characteristics of the Study Participants
Baseline Characteristics, Blood Pressures, and Laboratory Values
Baseline Characteristics of the Subjects*
Women’s Health Study: Baseline Characteristics Part 1
Characteristics of Participants in the Nurses Health Study According to Alcohol Intake Meir J.Stampfer et al N Engl J Med 2005;352:
Community-Based Argentine Tango Dance Program Is Associated With Increased Activity Participation Among Individuals With Parkinson's Disease  Erin R.
Entry, Randomization, and Follow-up of Patients in the Hypertension in the Very Elderly Trial Of the 461 patients who did not meet the protocol criteria,
Baseline Characteristics of Elderly Participants in the Cardiovascular Health Study,According to Quintiles of Cystatin C Michael G.Shlipak et al N Engl.
Baseline Characteristics of the Patients – Part I
RECORD Study: Enrollment and Outcomes
Change in (A) systolic blood pressure and (B) diastolic blood pressure over 5 years in response to 12-week intensive lifestyle intervention in a real-world.
Volume 128, Issue 4, Pages (April 2005)
Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle.
Fig. 2. Efficacy endpoints among treatment groups: least square (LS) mean changes from baseline in the WOMAC-pain subscale (A), total WOMACOA index score.
Clinical responses to therapy from baseline to week 24 and end point with last observation carried forward (LOCF). Clinical responses to therapy from baseline.
A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary.
Presentation transcript:

Enrollment and Retention T.A. Wadden, N Engl J Med 2005; 353: 2111-20

Baseline Characteristics of the Subjects* T.A. Wadden, N Engl J Med 2005; 353: 2111-20

Mean (±SE) Weight Loss in the Four Groups, as Determined by an Intention-to-Treat Analysis (A) and a Last-Observation-Carried-Forward Analysis (B) T.A. Wadden, N Engl J Med 2005; 353: 2111-20

Mean (±SE) Weight Loss at One Year in the Combined-Therapy Group and the Group Treated by Lifestyle Modification Alone among Subjects in the Lowest and Highest Thirds of Adherence for Completing Food-Intake Records during the First 18 Weeks T.A. Wadden, N Engl J Med 2005; 353: 2111-20

Flow of Participants Through the Trial T.A. Wadden, N Engl J Med 2005; 353: 2111-20

Changes in Cardiovascular Risk Factors at Week 52 in the Four Groups,as Determined by a Last-Observation- Carried-Forward Analysis* T.A. Wadden, N Engl J Med 2005; 353: 2111-20

Changes in Blood Pressure and Pulse during One Year of Treatment in the Four Groups,as Determined by a Last-Observation-Carried-Forward Analysis* T.A. Wadden, N Engl J Med 2005; 353: 2111-20